StockNews.com initiated coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Free Report) in a research report sent to investors on Saturday. The firm issued a hold rating on the biotechnology company’s stock. Infinity Pharmaceuticals Stock Performance Infinity Pharmaceuticals has a 1 year low of $0.01 and a 1 year high of $0.01. The stock’s 50-day […]
StockNews.com began coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Free Report) in a report released on Tuesday. The brokerage issued a hold rating on the biotechnology company’s stock. Infinity Pharmaceuticals Stock Performance INFI opened at $0.02 on Tuesday. The stock has a market cap of $1.91 million, a price-to-earnings ratio of -0.05 and a […]
StockNews.com assumed coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Free Report) in a research note issued to investors on Sunday morning. The firm issued a hold rating on the biotechnology company’s stock. Infinity Pharmaceuticals Stock Performance Shares of NASDAQ:INFI opened at $0.10 on Friday. Infinity Pharmaceuticals has a 1 year low of $0.08 and […]
Infinity Pharmaceuticals, Inc. (NASDAQ:INFI – Get Free Report) was the target of a significant increase in short interest in the month of August. As of August 15th, there was short interest totalling 1,970,000 shares, an increase of 114.4% from the July 31st total of 918,900 shares. Based on an average daily volume of 3,200,000 shares, […]
Equities researchers at StockNews.com initiated coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Free Report) in a report released on Saturday. The firm set a “hold” rating on the biotechnology company’s stock. Infinity Pharmaceuticals Stock Performance INFI opened at $0.21 on Friday. The firm has a market cap of $18.93 million, a P/E ratio of […]